27.10.2016 23:18:37
|
Amgen Inc. Q3 Profit Climbs 10%
(RTTNews) - Amgen Inc. (AMGN) released earnings for its third quarter that gained ground compared to the same period last year.
The company said its bottom line advanced to $2.28 billion, or $3.02 per share. This was higher than $2.08 billion, or $2.72 per share, in last year's third quarter.
Analysts had expected the company to earn $2.79 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company said revenue for the quarter rose 1.6% to $5.81 billion. This was up from $5.72 billion last year.
Amgen Inc. earnings at a glance:
-Earnings (Q3): $2.28 Bln. vs. $2.08 Bln. last year. -Earnings Growth (Y-o-Y): 9.6% -EPS (Q3): $3.02 vs. $2.72 last year. -EPS Growth (Y-o-Y): 11.0% -Analysts Estimate: $2.79 -Revenue (Q3): $5.81 Bln vs. $5.72 Bln last year. -Revenue Change (Y-o-Y): 1.6%
-Guidance: Full year EPS guidance: $11.40-$11.55 Full year revenue guidance: $22.6-$22.8 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Amgen Inc.mehr Nachrichten
10.03.25 |
Schwache Performance in New York: Dow Jones verbucht zum Handelsende Verluste (finanzen.at) | |
10.03.25 |
Dow Jones aktuell: Dow Jones am Montagnachmittag in Rot (finanzen.at) | |
10.03.25 |
Schwacher Handel in New York: Dow Jones schwächelt (finanzen.at) | |
10.03.25 |
Dow Jones 30 Industrial-Titel Amgen-Aktie: So viel Gewinn hätte ein Investment in Amgen von vor 3 Jahren eingebracht (finanzen.at) | |
10.03.25 |
Schwache Performance in New York: Dow Jones beginnt die Montagssitzung in der Verlustzone (finanzen.at) | |
07.03.25 |
Freundlicher Handel: So entwickelt sich der Dow Jones am Nachmittag (finanzen.at) | |
07.03.25 |
Schwacher Handel: Dow Jones liegt mittags im Minus (finanzen.at) | |
07.03.25 |
Impulsarmer Handel in New York: Dow Jones pendelt zum Start des Freitagshandels um seinen Schlusskurs vom Donnerstag (finanzen.at) |
Analysen zu Amgen Inc.mehr Analysen
Aktien in diesem Artikel
Amgen Inc. | 287,75 | -1,81% |
|